Mandate

Vinge advises Smart Eye in connection with a capital procurement of MSEK 220

November 01, 2021 Capital Markets and Public M&A

Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 220 to Smart Eye.

The subscription price of SEK 183 SEK, which corresponded to the closing price on Nasdaq First North Growth Market, was determined through an accelerated book-building procedure arranged by Carnegie. The proceeds will primarily be used to finance the acquisition of iMotions A/S, which was published on the same day.

Vinge’s team primarily consisted of Anders StridEdin AgicOscar Lunde and Adrian Filipovic.

Related

Vinge advises ABG Sundal Collier in connection with Conapto's issue of subsequent senior secured bonds of SEK 500 million

Vinge has advised ABG Sundal Collier as arranger in connection with Conapto Holding AB (publ)'s issue of subsequent senior secured bonds of SEK 500 million under the existing framework of SEK 2 billion.
April 24, 2026

Vinge advises Sobro on its investment in Västkustens Konstruktionsbyrå

Västkustens Konstruktionsbyrå has decided to broaden its ownership structure by bringing in Sobro as a new co-partner and majority shareholder. The founders will remain with the company as the CEO and CTO respectively, and as significant shareholders. Västkustens Konstruktionsbyrå is an engineering consultancy company based in Gothenburg with cutting-edge expertise in project management, civil engineering and design.
April 23, 2026

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026